These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9186398)

  • 21. [Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids].
    Voltz R; Hohlfeld R
    Nervenarzt; 1992 Dec; 63(12):773-5. PubMed ID: 1494395
    [No Abstract]   [Full Text] [Related]  

  • 22. [Steroid therapy for multiple sclerosis].
    Oishi C; Sakuta M
    Nihon Rinsho; 2003 Aug; 61(8):1361-6. PubMed ID: 12962024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dramatic response of scarring scalp discoid lupus erythematosus (DLE) to intravenous methylprednisolone, oral corticosteroids, and hydroxychloroquine in a 5-year-old child.
    Miettunen PM; Bruecks A; Remington T
    Pediatr Dermatol; 2009; 26(3):338-41. PubMed ID: 19706100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal versus systemic corticosteroids in the treatment of multiple sclerosis: results of a pilot study.
    Heun R; Sliwka U; Rüttinger H; Schimrigk K
    J Neurol; 1992 Jan; 239(1):31-5. PubMed ID: 1541966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Megadose corticosteroids in multiple sclerosis.
    Kupersmith MJ; Kaufman D; Paty DW; Ebers G; McFarland H; Johnson K; Reingold S; Whitaker J
    Neurology; 1994 Jan; 44(1):1-4. PubMed ID: 8290041
    [No Abstract]   [Full Text] [Related]  

  • 26. Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.
    Lyons PR; Newman PK; Saunders M
    J Neurol Neurosurg Psychiatry; 1988 Feb; 51(2):285-7. PubMed ID: 3346696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cortisol suppression in corticoid therapy. Comments on the contribution by R. Voltz and R. Hohlfeld. Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids].
    Haupts M; Schlüter T; Gehlen W
    Nervenarzt; 1993 Jun; 64(6):413. PubMed ID: 8332236
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pulse therapy in the treatment of optic neuritis in multiple sclerosis].
    Neroev VV; Karlova IZ; Guseva MR; Zaĭtseva OV; Boĭko SIu; Sidorenko EI; Dubovskaia LA; Budzinskaia MV; Boĭko AN
    Vestn Oftalmol; 2003; 119(5):28-31. PubMed ID: 14598491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Duration of rheumatic activity in patients treated with oral corticoids vs. pulse therapy].
    Couto AA; de Oliveira GM; Campos AL; Alves ML; Mansur EM; Pareto Júnior RC; Carneiro RD
    Arq Bras Cardiol; 1987 Jun; 48(6):371-3. PubMed ID: 3446135
    [No Abstract]   [Full Text] [Related]  

  • 30. [Corticoids and multiple sclerosis].
    Defer G; Cesaro P; Degos JD
    Ann Med Interne (Paris); 1994 Jun; 145 Suppl 2():37-41. PubMed ID: 8074340
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evoked potentials with intrathecal and systemic corticosteroid therapy in multiple sclerosis].
    Heun R; Emser W; Schimrigk K
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1989 Jun; 20(2):88-91. PubMed ID: 2503359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticosteroids treatment.
    Pozzilli C; Marinelli F; Romano S; Bagnato F
    J Neurol Sci; 2004 Aug; 223(1):47-51. PubMed ID: 15261560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes mellitus induced in a dog after administration of corticosteroids and methylprednisolone pulse therapy.
    Jeffers JG; Shanley KJ; Schick RO
    J Am Vet Med Assoc; 1991 Jul; 199(1):77-80. PubMed ID: 1885333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis.
    de Seze J; Chapelotte M; Delalande S; Ferriby D; Stojkovic T; Vermersch P
    Mult Scler; 2004 Oct; 10(5):596-7. PubMed ID: 15471379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Home administration of intravenous methylprednisolone for multiple sclerosis relapses: the experience of French multiple sclerosis networks.
    Créange A; Debouverie M; Jaillon-Rivière V; Taithe F; Liban D; Moutereau A; Clavelou P; Defer G
    Mult Scler; 2009 Sep; 15(9):1085-91. PubMed ID: 19556312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressive effect of glucocorticoids on TNF-alpha production is associated with their clinical effect in multiple sclerosis.
    van Winsen LM; Polman CH; Dijkstra CD; Tilders FJ; Uitdehaag BM
    Mult Scler; 2010 Apr; 16(4):500-2. PubMed ID: 20086025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes following corticosteroid administration in patients with delayed diagnosis of spinal arteriovenous fistulas.
    Nasr DM; Brinjikji W; Rabinstein AA; Lanzino G
    J Neurointerv Surg; 2017 Jun; 9(6):607-610. PubMed ID: 27260973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous dexamethasone vs methylprednisolone pulse therapy in the treatment of acute endothelial graft rejection.
    Tandon R; Verma K; Chawla B; Sharma N; Titiyal JS; Kalaivani M; Vajpayee RB
    Eye (Lond); 2009 Mar; 23(3):635-9. PubMed ID: 18292787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Corticosteroid treatment].
    Tomioka R
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():187-90. PubMed ID: 26480698
    [No Abstract]   [Full Text] [Related]  

  • 40. [Randomized controlled trial of high-dose peroral methylprednisolone in attacks of multiple sclerosis].
    Sellebjerg F; Frederiksen JL; Nielsen PM; Olesen J
    Ugeskr Laeger; 1999 Nov; 161(48):6625-9. PubMed ID: 10643347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.